Biogen, wrestling MS rivals, touts 10 year-plus Tecfidera data

Biogen's Tecfidera has managed to keep growing sales as competition in multiple sclerosis intensified. Now, the company is touting data that its new rivals can't match. At a medical conference in Stockholm, Biogen said Tecfidera remained safe and effective for at least a decade.